Key statistics
On Friday, Novocure Ltd (NVCR:NSQ) closed at 10.99, 11.91% above the 52 week low of 9.82 set on Feb 09, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 12.54 |
|---|---|
| High | 12.99 |
| Low | 10.93 |
| Bid | 11.00 |
| Offer | 11.08 |
| Previous close | 12.53 |
| Average volume | 3.73m |
|---|---|
| Shares outstanding | 111.98m |
| Free float | 100.99m |
| P/E (TTM) | -- |
| Market cap | 1.23bn USD |
| EPS (TTM) | -1.61 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Press releases
- U.S. FDA Approves Novocure’s Optune Pax® for the Treatment of Locally Advanced Pancreatic Cancer
- Novocure Announces Preliminary Full Year and Fourth Quarter 2025 Performance and Provides Company Update
- Novocure to Present at 44th Annual J.P. Morgan Healthcare Conference
- Novocure Appoints Company President Frank Leonard as Chief Executive Officer
- Novocure to Participate in 37th Annual Piper Sandler Healthcare Conference
More ▼
